Curaleaf (OTCMKTS:CURLF) Issues Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Curaleaf (OTCMKTS:CURLF - Get Free Report) announced its quarterly earnings results on Monday. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.09, Zacks reports. Curaleaf had a negative net margin of 14.82% and a negative return on equity of 13.67%. The company had revenue of $331.05 million during the quarter, compared to analyst estimates of $331.87 million.

Curaleaf Stock Down 6.3 %

CURLF traded down $0.07 during trading on Thursday, hitting $1.04. The company had a trading volume of 638,504 shares, compared to its average volume of 741,974. The company has a market capitalization of $687.05 million, a PE ratio of -3.59 and a beta of 0.57. Curaleaf has a one year low of $0.88 and a one year high of $6.40. The firm's 50-day moving average price is $1.43 and its 200 day moving average price is $2.17. The company has a quick ratio of 0.51, a current ratio of 1.11 and a debt-to-equity ratio of 0.85.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Cormark lowered shares of Curaleaf from a "moderate buy" rating to a "hold" rating in a report on Thursday, November 7th. Roth Capital raised shares of Curaleaf to a "strong-buy" rating in a report on Sunday, November 10th.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.